Moreover, human prostate cancer cell EVs (derived from PC-3 and DU-145 cell lines) express NKG2D ligands on their surface that downregulated NKG2D expression in effector lymphocytes [209]. This evidence concerns the gene KLRK1 and prostate carcinoma.